Preferred Name |
Deferoxamine |
|
Synonyms |
|
|
Definitions |
An iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and siderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile. This agent does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C416 |
|
ALT_DEFINITION |
An iron-chelating agent that removes iron from tumors by inhibiting DNA synthesis and causing cancer cell death. It is used in conjunction with other anticancer agents in pediatric neuroblastoma therapy. |
|
CAS_Registry |
70-51-9 |
|
CHEBI_ID |
CHEBI:4356 |
|
Chemical_Formula |
C25H48N6O8 |
|
code |
C416 |
|
Contributing_Source |
CTRP FDA |
|
definition |
An iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and siderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile. This agent does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. (NCI04) |
|
Display_Name |
Deferoxamine |
|
FDA_UNII_Code |
J06Y7MXW4D |
|
Has_Salt_Form | ||
Has_Target | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C173383 http://purl.obolibrary.org/obo/NCIT_C173381 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C116977 http://purl.obolibrary.org/obo/NCIT_C116978 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
Is_Value_For_GDC_Property | ||
label |
Deferoxamine |
|
Legacy Concept Name |
Deferoxamine |
|
Maps_To |
Deferoxamine |
|
NSC Number |
527604 |
|
Preferred_Name |
Deferoxamine |
|
prefixIRI |
NCIT:C416 |
|
prefLabel |
Deferoxamine |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0011145 |
|
subClassOf |